Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.627 EUR | +0.16% | -7.25% | +13.79% |
Apr. 11 | Poxel: CDC falls below the 10% threshold | CF |
Feb. 15 | Poxel S.A. Reports Unaudited Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
26.35M | - | - | - | - | - | |
115B | ||||||
107B | ||||||
21.6B | - | |||||
22.31B | - | |||||
19.19B |
- Stock Market
- Equities
- POXEL Stock
- Charts Poxel
- Sector Chart